Last reviewed · How we verify
NCT06674369
Ongoing Effect of Expansion Prisms Following the Discontinuation of Use on Visual Field Enlargement and Retrograde Ganglion Cell Degeneration in Homonymous Hemianopia Patients
trial testing Peli prism for hemianopia in Homonymous Hemianopsia in 15 participants. Participants enrolled and being followed up; not accepting new ones.
18 October 2022
Quick facts
| Lead sponsor | Okan University |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 15 |
| Start date | 28 August 2022 |
| Primary completion | 18 October 2022 |
| Estimated completion | 30 October 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Peli prism for hemianopia
Conditions studied
- Homonymous Hemianopsia — all drugs for Homonymous Hemianopsia →
Sponsor
Okan University
Who can join
Adults 18 Months to 55 Months, any sex, with Homonymous Hemianopsia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to learn about the long-term effects of Pelli prism in Hemianopia patients who take Prisms for awareness of the area they cannot see. The main question it aims to answer is: Does the field enlargement observed with the prism continues after the prism is removed? Participants already using Peli prisms as part of their regular medical care for Hemianopia, in the upcoming routine controls their field of vision enlargements will be examined.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06674369
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Homonymous Hemianopsia
Currently open trials in the same condition.
- NCT07358832 — Neuromodulation Through Multisensory Stimulation for Visual Field Deficits in the Subacute Stage of Disease · NA · recruiting
Other Okan University trials
Trials by the same sponsor.
- NCT07457034 — Digital Follow-Up and Nursing Education in Bariatric Surgery Patients · NA · not yet recruiting
- NCT07457905 — THE RELATIONSHIP BETWEEN PAIN ANXIETY AND POST-OPERATIVE PAIN IN PATIENTS UNDERGOING CHOLECYSTECTOMY SURGERY · not yet recruiting
- NCT07462832 — Effect of Connective Tissue Massage in Low Back Pain · NA · not yet recruiting
- NCT07408401 — Exercise Program Combined With Ergonomic Training in Textile Workers · NA · not yet recruiting
- NCT07276126 — The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlle · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06674369 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Okan University
- Last refreshed: 5 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06674369.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing